Neena M Patil Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Neena M Patil is EVP & Chief Legal Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 37,118 shares of JAZZ, which is worth approximately $4.64 Million. The most recent transaction as insider was on Jan 17, 2025, when has been sold 1,905 shares (Ordinary Shares) at a price of $122.62 per share, resulting in proceeds of $233,591. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.1K

1.34% 3M change

13.47% 12M change

Total Value Held $4.64 Million

Neena M Patil Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 17 2025	SELL Payment of exercise price or tax liability	$233,591 $122.62 p/Share	1,905 Reduced 4.88%	37,118 Ordinary Shares
Jan 17 2025	BUY Grant, award, or other acquisition	-	5,864 Added 13.06%	39,023 Ordinary Shares
Nov 08 2024	SELL Open market or private sale	$456,617 $123.41 p/Share	3,700 Reduced 10.07%	33,048 Ordinary Shares
May 03 2024	SELL Open market or private sale	$548,250 $109.65 p/Share	5,000 Reduced 12.01%	36,629 Ordinary Shares
Mar 05 2024	SELL Payment of exercise price or tax liability	$403,362 $117.53 p/Share	3,432 Reduced 7.62%	41,629 Ordinary Shares
Mar 01 2024	BUY Grant, award, or other acquisition	-	12,348 Added 21.51%	45,061 Ordinary Shares
Jan 17 2024	SELL Payment of exercise price or tax liability	$197,279 $119.13 p/Share	1,656 Reduced 4.82%	32,713 Ordinary Shares
Jan 17 2024	BUY Grant, award, or other acquisition	-	5,087 Added 12.89%	34,369 Ordinary Shares
Sep 01 2023	SELL Open market or private sale	$216,375 $144.25 p/Share	1,500 Reduced 4.89%	29,186 Ordinary Shares
Aug 15 2023	SELL Open market or private sale	$104,692 $139.59 p/Share	750 Reduced 2.39%	30,686 Ordinary Shares
Aug 07 2023	SELL Sale (or disposition) back to the issuer	$182,798 $131.51 p/Share	1,390 Reduced 4.23%	31,436 Ordinary Shares
Jun 01 2023	SELL Open market or private sale	$204,784 $127.99 p/Share	1,600 Reduced 4.65%	32,826 Ordinary Shares
Mar 05 2023	SELL Payment of exercise price or tax liability	$274,565 $142.78 p/Share	1,923 Reduced 5.3%	34,339 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	9,419 Added 20.62%	36,262 Ordinary Shares
Nov 16 2022	SELL Open market or private sale	$499,613 $142.34 p/Share	3,510 Reduced 11.59%	26,769 Ordinary Shares
Aug 05 2022	SELL Payment of exercise price or tax liability	$203,064 $153.72 p/Share	1,321 Reduced 4.18%	30,279 Ordinary Shares
Jun 06 2022	SELL Open market or private sale	$152,150 $152.15 p/Share	1,000 Reduced 3.07%	31,600 Ordinary Shares
May 10 2022	SELL Bona fide gift	-	161 Reduced 0.49%	32,516 Ordinary Shares
May 06 2022	SELL Open market or private sale	$45,560 $153.92 p/Share	296 Reduced 0.9%	32,677 Ordinary Shares
Mar 05 2022	SELL Payment of exercise price or tax liability	$189,063 $153.96 p/Share	1,228 Reduced 3.59%	32,973 Ordinary Shares
Mar 03 2022	BUY Grant, award, or other acquisition	-	8,886 Added 20.62%	34,201 Ordinary Shares
Aug 05 2021	SELL Payment of exercise price or tax liability	$147,451 $148.49 p/Share	993 Reduced 3.79%	25,233 Ordinary Shares
Mar 05 2021	SELL Payment of exercise price or tax liability	$113,842 $164.75 p/Share	691 Reduced 2.57%	26,147 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	7,270 Added 21.31%	26,838 Ordinary Shares

Also insider at

TFX

TELEFLEX INC Healthcare

Director

NMP

Neena M Patil

EVP & Chief Legal Officer

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account